CTLA4 and cancer: These combination strategies often include cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) blockade, chemotherapy, radiotherapy, or cancer vaccines, which collectively enhance antigen presentation and T cell activation, thereby improving antitumor responses.